Health Care/Hospital
Start of bridging pharmacokinetic and safety clinical trial of a novel solid pharmaceutical composition of AMPK activator O304
STOCKHOLM, Aug. 17, 2020 /PRNewswire/ -- In previous Phase I and Phase IIa clinical trials in healthy subjects and in type 2 diabetics, the small molecule AMPK activator compound O304 was administered as a suspension and with limited oral bioavailability. A novel formulation of O304 has now been ...
2020-08-17 22:13
2431
Sirtex Medical announces partnership with Magle Chemoswed
Collaboration grants Sirtex global use of innovative technology to develop novel imaging agent for interventional oncology WOBURN, Massachusetts, Aug. 17, 2020 /PRNewswire/ -- Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced a coll...
2020-08-17 20:00
2253
I-Mab Announces First Patient Dosed in Phase 1b Study of Plonmarlimab in Rheumatoid Arthritis in China
SHANGHAI and GAITHERSBERG, Md., Aug. 17, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the first patient has been dosed with plonmarlimab ...
2020-08-17 20:00
3364
CARsgen Announces the Publication of a Novel CAR-T Technology that Improves the Efficacy of CAR-T cells Against Solid Tumors without Requiring Preconditioned Lymphodepletion
SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- CARsgen Therapeutics, a leader in developing novel CAR-T cell therapies against solid tumors, today announced its publication of the 7×21 CAR-T technology in CLINICAL CANCER RESEARCH. The article is titled "Coexpression of IL-7 and CCL21 increases efficacy ...
2020-08-17 18:00
3443
First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody
HANGZHOU, China and SHAOXING, China, Aug. 17, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today dosing of the first HBV patient in Phase IIa clinical trial of ASC22, which is a first-in-class, subcutaneously administered PD-L1 antibody. ASC22(Envafolimab) Phase IIa clin...
2020-08-17 08:30
3652
iHerb Announces Major Global Delivery Expansion
PASADENA, California, Aug. 17, 2020 /PRNewswire/ -- Global health and beauty e-commerce leader iHerb is expanding its global availability to 23 additional countries, one of the largest expansions in the company's history. This is in addition to the 165 countries and territories iHerb already serv...
2020-08-17 08:29
3723
Sai Life Sciences opens new, state-of-the-art Research & Technology Centre in Hyderabad
HYDERABAD, India, Aug. 17, 2020 /PRNewswire/ -- Sai Life Sciences, one of
India's fastest growing Contract Development & Manufacturing Organizations
(CDMOs)
2020-08-17 08:00
3560
China's First Trastuzumab Biosimilar Approved by NMPA
SHANGHAI, Aug. 17, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced onAugust 14 that the trastuzumab biosimilar HLX02, developed and manufactured by Henlius independently, has been approved by the National Medical Products Administration (NMPA). On 27th July, HLX02 (EU bran...
2020-08-17 08:00
3981
Ascentage Pharma Becomes a Constituent of Three Major Indexes Including Hang Seng Composite Index
SUZHOU, China, and ROCKVILLE, MD., Aug. 17, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company has been s...
2020-08-17 07:30
2877
Memo Therapeutics AG and Northway Biotechpharma Collaborate on the Fast-Track Manufacturing of a SARS-CoV-2-Neutralizing Antibody for the Therapy of COVID-19
SCHLIEREN, Switzerland and VILNIUS, Lithuania, Aug. 15, 2020 /PRNewswire/ -- Swiss biotech companyMemo Therapeutics AG (MTx) and Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announce a new partnership to manufacture MTx...
2020-08-15 08:36
4519
Lee's Pharm Announced 2020 Interim Results Positive Profit Alert
HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group", Stock Code: 950), an integrated research-driven and market-oriented pharmaceutical group inChina, is pleased to announce that it is anticipated that the Group's will record a significant ...
2020-08-14 23:49
10226
China Jo-Jo Drugstores Reports First Quarter 2021 Financial Results
HANGZHOU, China, Aug. 14, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its fina...
2020-08-14 21:00
7791
China Pharma Holdings, Inc. Reports Second Quarter 2020 Financial Results
HAIKOU CITY, China, Aug. 14, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the qu...
2020-08-14 18:30
5817
Family Mask Supports UNGC Leaders' Summit 2020
HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Family Mask is honoured to be an official supporting organization of United Nations Global Compact Leaders' Summit 2020, where more than 20,000 sustainability champions gathered over 26 hours of continuous virtual programming to address the private sector'...
2020-08-14 15:30
3644
Bushu Pharmaceuticals Announces Major Expansion Program
KAWAGOE, Japan, Aug. 14, 2020 /PRNewswire/ -- - Japan's Premier CDMO Will Invest $100m to Expand Capacity and Portfolio - Bushu Pharmaceuticals Ltd., one of Japan's largest contract manufacturers of pharmaceutical products, announced onAugust 14 a major capital program costing $100 million to ex...
2020-08-14 14:00
2307
Sinopharm Tech plans to purchase 337 tons Meltblown Fabric
HONG KONG, August 14, 2020 /PRNewswire/ -- Sinopharm Tech Holdings Limited ("Sinopharm Tech" and its subsidiaries, together, the "Group", stock code: 8156) is pleased to announce that, as of 13 August, 2020, the subsidiary of the Group has entered into product sales agreements with a branch of Pe...
2020-08-14 09:18
4384
Violet Defense's UV Disinfection Technology Proven Up to 99.99% Effective Against Coronavirus
ORLANDO, Florida, Aug. 14, 2020 /PRNewswire/ -- Violet Defense, the only known manufacturer of pulsed Xenon UV disinfection devices that can be installed and operated autonomously, has announced that its technology has been independently validated to kill up to 99.99% of Human coronavirus, strain...
2020-08-14 08:04
4485
Hankyung.com's introduces: "Seoul Made" PPE kits, targeting US Market
SEOUL, South Korea, Aug. 13, 2020 /PRNewswire/ -- "Seoul Made" PPE kits designed with Korean cultural themes and made by small businesses inSeoul, was delivered to New York on August 13th With many stakeholders of New Jersey, New York, Brooklyn, Chamber of Commerce, and other related agencies e...
2020-08-14 08:00
1846
Aquavit Pharmaceuticals, Inc. Secures Court Order on Compensatory Sanctions Against Counterfeiters for Contempt on Patent and Trademark Infringement Case
NEW YORK, Aug. 14, 2020 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. ("Aquavit") secured Compensatory sanctions against counterfeiters inthe United States District Court for the Southern District of New York in a civil action against U-Bio Med, Inc., et al. The judgment orders all profits earne...
2020-08-14 02:32
4014
Zai Lab Announces Financial Results for Six Months Ended June 30, 2020 and Corporate Updates
SHANGHAI and SAN FRANCISCO, Aug. 13, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial-stage biopharmaceutical company, today announced financial results for the six months ended June 30, 2020 and corporate updates. "This year we have continued to build Zai Lab's lead...
2020-08-13 22:38
6622
Week's Top Stories
Most Reposted
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 303 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 274 media titles]
2024-05-16 09:39
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
[Picked up by 272 media titles]
2024-05-10 15:20
Where does China's production capacity come from?
[Picked up by 258 media titles]
2024-05-10 12:01Most Read
Huawei Launching the All-Scenario Smart Telecom Power Solutions
2024-05-11 17:52
9065
Central Embassy, celebrates its 10th anniversary with a world-class immersive presentation--the first of its kind in Thailand--by renowned artist Daniel Arsham
2024-05-10 15:20
8421
Where does China's production capacity come from?
2024-05-10 12:01
8252
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering
2024-05-10 21:20
4997